clinicaltrialsarena3 小时
MindMed doses first subject in Phase III Panorama study of GAD tablet
MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...
clinicaltrialsarena20 小时
MSD halts Winrevair trial due to success of previous study
MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...
clinicaltrialsarena21 小时
EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial
The EMA has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer trial in Europe to add 11 new sites.